Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BRAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZBTB20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SETDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGST3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM196 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CABP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BICC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM26-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C5orf63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHC1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP1S3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUSD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KANSL1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on